These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33383364)

  • 1. Impact of psychiatric distress and physical disability on quality of life in neuromyelitis optica spectrum disorder and chronic autoimmune demyelinating polyneuropathies.
    Yalachkov Y; Soydaş D; Uhlmann V; Behrens M; Frisch S; Foerch C; Gehrig J
    Mult Scler Relat Disord; 2021 Feb; 48():102711. PubMed ID: 33383364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life of patients with multiple sclerosis and neuromyelitis optica spectrum disorders: Cross-sectional and longitudinal analysis.
    Kim S; Lee EJ; Kim KW; Seo D; Moon S; Kim KK; Lim YM
    Mult Scler Relat Disord; 2022 Feb; 58():103500. PubMed ID: 35032884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resilience and depression/anxiety symptoms in multiple sclerosis and neuromyelitis optica spectrum disorder.
    Nakazawa K; Noda T; Ichikura K; Okamoto T; Takahashi Y; Yamamura T; Nakagome K
    Mult Scler Relat Disord; 2018 Oct; 25():309-315. PubMed ID: 30176401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mediating effect of health-related hardiness on the degree of physical disability and perceived stress in Chinese female patients with neuromyelitis optica spectrum disorder.
    Xu Y; Su X; Lu X; Zhang M; Wang W; Ding D; Chao Q; Jiang H
    Mult Scler Relat Disord; 2019 Oct; 35():67-72. PubMed ID: 31351263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of quality of life, anxiety, depression, and fatigue among patients with neuromyelitis optica spectrum disorder and multiple sclerosis: The first report from Iran.
    Barzegar M; Badihian S; Mirmosayyeb O; Ashtari F; Jamadi M; Emami S; Jahani L; Safavi A; Shaygannejad V
    Mult Scler Relat Disord; 2018 May; 22():161-165. PubMed ID: 29775851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromyelitis optica spectrum disorder in China: Quality of life and medical care experience.
    Huang W; ZhangBao J; Chang X; Wang L; Zhao C; Lu J; Wang M; Ding X; Xu Y; Zhou L; Li D; Behne MK; Behne JM; Yeaman MR; Katz E; Lu C; Quan C;
    Mult Scler Relat Disord; 2020 Nov; 46():102542. PubMed ID: 33296965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantifying the relationship between disability progression and quality of life in patients treated for NMOSD: Insights from the SAkura studies.
    Levy M; Haycox AR; Becker U; Costantino C; Damonte E; Klingelschmitt G; von Büdingen HC; Wallenstein G; Maio DD; Szczechowski L
    Mult Scler Relat Disord; 2022 Jan; 57():103332. PubMed ID: 35158426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life in neuromyelitis optica spectrum disorder patients in an Argentinean cohort.
    Carnero Contentti E; Eizaguirre MB; López PA; Rojas JI; Tkachuk V; Alonso R
    Mult Scler Relat Disord; 2022 Mar; 59():103647. PubMed ID: 35124305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysphagia in neuromyelitis optica spectrum disorder and multiple sclerosis: A comparison of frequency, severity, and effects on quality of life.
    Afsharzadeh M; Mirmosayyeb O; Vaheb S; Shaygannejad A; Maracy M; Shaygannejad V
    Mult Scler Relat Disord; 2024 Jul; 87():105640. PubMed ID: 38692153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors that impact health-related quality of life in neuromyelitis optica spectrum disorder: anxiety, disability, fatigue and depression.
    Shi Z; Chen H; Lian Z; Liu J; Feng H; Zhou H
    J Neuroimmunol; 2016 Apr; 293():54-58. PubMed ID: 27049562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatigue in patients with neuromyelitis optica spectrum disorder and its impact on quality of life.
    Seok JM; Choi M; Cho EB; Lee HL; Kim BJ; Lee KH; Song P; Joo EY; Min JH
    PLoS One; 2017; 12(5):e0177230. PubMed ID: 28542592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis.
    Yalachkov Y; Soydaş D; Bergmann J; Frisch S; Behrens M; Foerch C; Gehrig J
    Mult Scler Relat Disord; 2019 May; 30():33-37. PubMed ID: 30735970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential brainstem atrophy patterns in multiple sclerosis and neuromyelitis optica spectrum disorders.
    Lee CY; Mak HK; Chiu PW; Chang HC; Barkhof F; Chan KH
    J Magn Reson Imaging; 2018 Jun; 47(6):1601-1609. PubMed ID: 28990252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal cord involvement by atrophy and associations with disability are different between multiple sclerosis and neuromyelitis optica spectrum disorder.
    Nakamura Y; Liu Z; Fukumoto S; Shinoda K; Sakoda A; Matsushita T; Hayashida S; Isobe N; Watanabe M; Hiwatashi A; Yamasaki R; Kira JI
    Eur J Neurol; 2020 Jan; 27(1):92-99. PubMed ID: 31304648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric-onset multiple sclerosis in Brazilian patients: Clinical features, treatment response and comparison to pediatric neuromyelitis optica spectrum disorders.
    Fragomeni MO; Bichuetti DB; Oliveira EML
    Mult Scler Relat Disord; 2018 Oct; 25():138-142. PubMed ID: 30075406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicentric clinical and epidemiological comparison of neuromyelitis optica spectrum disorder with multiple sclerosis from India.
    Gupta S; Rehani V; Acharya R; Purohit P; Anadure R; Ahmad F; Soni R; Gupta A; Hiremath R
    Mult Scler Relat Disord; 2021 Jan; 47():102616. PubMed ID: 33166808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health utilities of patients with multiple sclerosis and neuromyelitis optica spectrum disorders in Thailand.
    Siritho S; Thavorncharoensap M; Chanatittarat C; Pasogpakdee P; Apiwattanakul M; Prayoonwiwat N; Chankrachang S; Riewpaiboon A; Chaikledkaew U
    Mult Scler Relat Disord; 2018 Aug; 24():151-156. PubMed ID: 30015079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of immunotherapies and prognostic predictors in neuromyelitis optica spectrum disorder: a prospective cohort study.
    Shi Z; Du Q; Chen H; Zhang Y; Qiu Y; Zhao Z; Wang J; Yan C; Zhang Q; Yang M; Zhou H
    J Neurol; 2020 Apr; 267(4):913-924. PubMed ID: 31776721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric comorbidities and suicidality among patients with neuromyelitis optica spectrum disorders in Argentina.
    Fernández VC; Alonso N; Melamud L; Villa AM
    Mult Scler Relat Disord; 2018 Jan; 19():40-43. PubMed ID: 29125969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of sleep complaints and quality of life between patients with neuromyelitis optica spectrum disorder (NMOSD) and healthy controls.
    Barzegar M; Sadeghi Bahmani D; Nehzat N; Kiani M; Hashemi N; Mirmosayyeb O; Brand S; Shaygannejad V
    Mult Scler Relat Disord; 2019 Jul; 32():81-87. PubMed ID: 31063950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.